Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009863
Filing Date
2023-05-15
Accepted
2023-05-15 16:20:45
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nhwk-20230331x10q.htm   iXBRL 10-Q 1412788
2 EX-31.1 nhwk-20230331xex31d1.htm EX-31.1 26396
3 EX-31.2 nhwk-20230331xex31d2.htm EX-31.2 25779
4 EX-32.1 nhwk-20230331xex32d1.htm EX-32.1 8759
5 EX-32.2 nhwk-20230331xex32d2.htm EX-32.2 9425
  Complete submission text file 0001558370-23-009863.txt   7817749

Data Files

Seq Description Document Type Size
6 EX-101.SCH nhwk-20230331.xsd EX-101.SCH 63262
7 EX-101.CAL nhwk-20230331_cal.xml EX-101.CAL 91603
8 EX-101.DEF nhwk-20230331_def.xml EX-101.DEF 227320
9 EX-101.LAB nhwk-20230331_lab.xml EX-101.LAB 576405
10 EX-101.PRE nhwk-20230331_pre.xml EX-101.PRE 434699
72 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20230331x10q_htm.xml XML 1344167
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 23922808
SIC: 2834 Pharmaceutical Preparations